<DOC>
	<DOC>NCT01694927</DOC>
	<brief_summary>The aim of this study is to evaluate the use of autologous expanded mesenchymal stem cells intralesional transplantation as a safe and potentially beneficial treatment for patients with spinal cord injury.</brief_summary>
	<brief_title>Autologous Mesenchymal Stem Cells in Spinal Cord Injury (SCI) Patients</brief_title>
	<detailed_description />
	<mesh_term>Wounds and Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>American Spinal Injury Association Impairment (ASIA) Scale A, B and C Cervical (under C4), thoracic o lumbar spine lesion Complete or Incomplete SCI Platelet count over 100.000/ul Acute SCI (less than 3 months) Active infectious diseases Pregnancy Neurodegenerative diseases Primary hematologic diseases Coagulopathies Hepatic dysfunction Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Spinal cord injury</keyword>
</DOC>